Eko Low Ejection Fraction Tool (ELEFT) vs VX1+

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by Volta Medical

AI Verdict

Eko Low Ejection Fraction Tool (ELEFT) is designed for early detection of low ejection fraction during routine physical exams, aiding in heart failure risk identification. In contrast, Volta Medical's VX1+ provides real-time AI-powered assistance to electrophysiologists for identifying abnormal electrograms during cardiac ablation procedures for atrial fibrillation and tachycardia. While both are cardiology AI tools, ELEFT focuses on non-invasive screening for chronic conditions, whereas VX1+ specializes in interventional guidance for acute arrhythmia procedures.

Choose Eko Low Ejection Fraction Tool (ELEFT) if…

Choose Eko Low Ejection Fraction Tool (ELEFT) if your primary goal is to non-invasively screen patients for early indicators of heart failure during routine physical examinations. This tool is ideal for clinicians, including family medicine practitioners and cardiologists, seeking to quickly identify low ejection fraction using a digital stethoscope and AI-powered analysis to aid in proactive patient management.

View Eko Low Ejection Fraction Tool (ELEFT) →

Choose VX1+ if…

Choose VX1+ if you are an electrophysiologist performing cardiac ablation procedures for atrial fibrillation or atrial tachycardia and require real-time AI-driven insights during the intervention. This software is specifically designed to assist in the identification of abnormal and spatio-temporal dispersed electrograms (DEs) within the operating room, integrating with existing EP mapping systems to enhance procedural precision.

View VX1+ →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Eko Low Ejection Fraction Tool (ELEFT) VX1+
Deployment Unknown Software, compatible with most multipolar catheters and mapping technologies used in operating rooms or electrophysiology labs.
FDA Status Cleared AI-estimated Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Eko Low Ejection Fraction Tool (ELEFT)

Eko Low Ejection Fraction Tool (ELEFT) integrates with familiar Eko digital stethoscopes and provides results in approximately 15 seconds during routine physical exams, making it highly accessible and easy to incorporate into existing workflows for a broad range of clinicians. VX1+ is designed for highly specialized cardiac ablation procedures, which are inherently more complex, even with its simple color-coded interface.

Clinical Value

Eko Low Ejection Fraction Tool (ELEFT)

ELEFT aids in the early detection of low ejection fraction, a key indicator of heart failure, during routine physical exams, addressing a widespread and often underdiagnosed condition with significant population-level impact. VX1+ assists electrophysiologists in real-time identification of abnormal electrograms during complex cardiac ablation procedures, aiming to improve the efficacy of a specialized intervention. While both offer significant value, ELEFT's potential for broad, early detection of a prevalent condition gives it an edge in overall clinical impact.

Pricing & Value

Tie

Neither ELEFT nor VX1+ provides publicly available pricing information, making a direct comparison of their pricing and value proposition impossible. Both are enterprise solutions, suggesting a significant investment, and require direct contact with sales for specific pricing details.

Enterprise Readiness

Eko Low Ejection Fraction Tool (ELEFT)

ELEFT is explicitly stated to be HIPAA compliant and offers a Business Associate Agreement (BAA), which are critical for enterprise adoption and data security in healthcare. While VX1+ is expected to meet these standards for a medical device handling patient data in the U.S., ELEFT's explicit confirmation provides greater assurance for enterprise readiness. Both are FDA-cleared and designed for integration into clinical workflows.

Innovation

Eko Low Ejection Fraction Tool (ELEFT)

ELEFT innovates by integrating AI-powered diagnostics into a common, non-invasive tool (the stethoscope) for early heart failure detection during routine physical exams, democratizing access to advanced diagnostics at the point of care. VX1+ is also highly innovative in applying AI to real-time, complex electrophysiology procedures to improve ablation targeting. However, ELEFT's broader applicability to primary care and its integration with a foundational clinical tool represent a more widespread innovation in healthcare delivery.

Support & Docs

Eko Low Ejection Fraction Tool (ELEFT)

Eko Health provides a dedicated help center for individual customers, options to schedule calls with customer experience, and a support ticket system, indicating structured support channels. For enterprise users of SENSORAu2122 (which includes ELEFT), a separate help center is available. Volta Medical's contact information is available, but specific details on support channels or comprehensive documentation for VX1+ are not as explicitly detailed or easily accessible through web search.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Eko Low Ejection Fraction Tool (ELEFT) VX1+
Tool Name Eko Low Ejection Fraction Tool (ELEFT) VX1+
Primary Function Aids clinicians in the early detection of low ejection fraction, a key indicator of heart failure, during routine physical exams. AI-powered software that assists electrophysiologists in real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation and atrial tachycardia.
Company Eko Health Volta Medical
Target Specialties Cardiology, Family Medicine, Internal Medicine Cardiology
Key AI Application AI-powered low ejection fraction detection Real-time identification of spatio-temporal dispersed electrograms (DEs) during AF and AT procedures
Integration/Compatibility Integrates with FDA-cleared Eko digital stethoscopes Compatibility with existing 510(k)-cleared catheters and specific data acquisition systems (e.g., Boston Scientific LabSystem Pro, GE HealthCare MacLab CardioLab EP Recording System, Abbott EnSite X 3D mapping system)

Videos

Demos, reviews, and walkthroughs featuring Eko Low Ejection Fraction Tool (ELEFT) and VX1+.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

ELEFT integrates into routine physical exams using Eko stethoscopes to aid in early detection of low ejection fraction, providing results in approximately 15 seconds. VX1+ integrates with existing EP recording and 3D mapping systems to assist electrophysiologists in real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation and atrial tachycardia.
ELEFT is a cloud-based solution that processes and stores data from Eko digital stethoscopes, and its platform, SENSORAu2122, offers EHR customization. VX1+ integrates with existing EP recording and 3D mapping systems, but direct automated EHR integration for broader hospital systems is not explicitly detailed in the provided information.
ELEFT's AI was trained on over 100,000 ECGs and echocardiogram pairs and clinically validated in a multi-site study of 3,456 patients, achieving 74.7% sensitivity and 77.5% specificity for detecting LVEF u2264 40%. VX1+ is designed to assist in identifying spatio-temporal dispersed electrograms during AF and AT procedures, with a 'Booster mode' for increased sensitivity, and its performance has been evaluated through non-clinical testing and a reader study.
ELEFT integrates into routine physical exams with a digital stethoscope, suggesting a potentially low learning curve for clinicians in primary care, family medicine, and internal medicine. VX1+ features a simple user interface with color coding for electrogram dispersion, implying a relatively intuitive learning curve for electrophysiologists, with training likely focusing on integrating its real-time insights into existing EP procedural workflows.
ELEFT provides rapid results in approximately 15 seconds during a physical exam, offering quick insights for early heart failure risk identification. While specific details on ongoing support for VX1+ are not provided, its real-time assistance during complex EP procedures indicates immediate value during the intervention.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.